Switching from Wegovy to Mounjaro dose conversion chart
With more weight loss medications available than ever before, it’s crucial to find the right one that fits your needs and lifestyle. Choosing the right medication can make all the difference in reaching your health goals and maintaining long-term success.
Key highlights
- Mounjaro can assist you in losing more weight than Wegovy, based on clinical trials that indicate an average weight loss of 20% or more over 12 to 18 months.
- Insurance may cover Mounjaro if prescribed for type 2 diabetes, making it cheaper than Wegovy for some individuals.
- Switching from Wegovy to Mounjaro requires a healthcare provider to adjust the dose carefully for safety and effectiveness.
- Always consult your healthcare professional before changing medications to weigh the potential benefits and risks.
Wegovy (semaglutide) and Mounjaro (tirzepatide) are popular injectable medications used for long-term weight management.
Switching weight-loss medications can be a major decision, especially if your current treatment isn’t working as well as you’d like. If Wegovy isn’t giving you the desired results or has side effects, you might consider Mounjaro as an alternative.
Mounjaro has gained attention for its potential to offer superior effectiveness in weight loss and reducing blood sugar levels, making it a popular alternative to Wegovy.
Are you considering switching from Wegovy to Mounjaro? This comprehensive guide explores the main reasons for the switch, benefits, dosage considerations, and important factors to discuss with your doctor before changing medications.
Understanding Wegovy and Mounjaro
Wegovy and Mounjaro are popular GLP-1 medications used for long-term weight loss. Both help control appetite and support weight management, but they work in different ways.
Wegovy
Wegovy (semaglutide) is an FDA-approved prescription injectable medication for chronic weight management in people with obesity (body mass index (BMI) of 30 or more) and overweight (BMI of 27 or more) with at least one weight-related condition. This once-weekly weight loss injection mimics a natural gut hormone called glucagon-like peptide-1 (GLP-1) receptor agonists to control hunger and make you feel full longer.
Wegovy, manufactured by Novo Nordisk, is FDA-approved to treat obesity, support long-term weight management, and reduce the risk of heart problems related to obesity.
- Dosage: Injected under the skin once a week, in dosage strengths ranging from 0.25 mg to 2.4 mg once weekly.
- Efficacy: Wegovy has been shown to help people lose significant weight. In clinical studies, users lost an average of 15-20% of their body weight when combined with diet and exercise.
- Side effects: Common side effects of Wegovy include nausea, vomiting, diarrhea, constipation, and stomach pain. Some people may also experience headaches or fatigue.
- Mechanism of action: Wegovy is a GLP-1 receptor agonist (glucagon-like peptide-1 receptor agonist) that helps treat obesity and promote weight loss by reducing appetite, slowing gastric emptying, and making you feel fuller longer.
Mounjaro
Mounjaro (tirzepatide) is a once-weekly subcutaneous injectable GLP-1/GIP receptor agonist approved by the FDA (U.S. Food and Drug Administration) in 2022 to help lower blood sugar levels in adults with type 2 diabetes. It is also prescribed off-label for weight loss when combined with diet and exercise.
Tirzepatide, the active ingredient in Mounjaro, helps reduce hunger and make you feel full by affecting the hormones that control appetite. It can also help boost metabolism and burn fat.
- Dosage: Injected under the skin once a week, in dosage strengths ranging from 2.5 mg to 15 mg once weekly.
- Efficacy: Mounjaro has strong HbA1c reductions and significant weight loss, often better than Wegovy and other GLP-1 medications. In a study of 2,500+ adults with obesity, the average participant lost 15% of their body weight on 5mg at 72 weeks, and 20% or more weight loss with higher doses.
- Side effects: Common side effects of Mounjaro include nausea, vomiting, and diarrhea. A combination of GLP-1 and GIP receptors can cause more side effects especially when starting treatment or escalating doses.
- Mechanism of action: Mounjaro works by activating both GLP-1 and GIP receptors, increasing insulin secretion, decreasing glucose production by the liver, reducing hunger and cravings, and promoting satiety leading to less food intake and weight loss.
This dual action may make Mounjaro more effective for weight management and blood glucose control than other GLP-1 medications that target only one receptor, like Ozempic and Wegovy (both manufactured by Novo Nordisk) which contain the active ingredient, semaglutide.
Why switch from Wegovy to Mounjaro
Switching from Wegovy to Mounjaro could help people lose more weight or manage Type 2 diabetes better. It could also be more affordable for some people depending on their insurance coverage and eligibility for manufacturer savings card programs.
If you’ve hit a weight loss plateau on Wegovy, you might want to try Mounjaro. If you’re on the highest dose of Wegovy and still haven’t reached your weight goal, tirzepatide might help you surpass the plateau. However, keep in mind that neither Wegovy nor Mounjaro are quick fixes; both should be used along with changes in diet and lifestyle.
Improved weight loss results with Mounjaro
Switching to Mounjaro could help some people lose more weight. In a study with over 18,000 adults, those taking tirzepatide (Mounjaro) lost about 7% more weight on average than those taking semaglutide (Wegovy) over 12 months.
Mounjaro has a stronger effect on weight loss, making it a good option for people who aren’t reaching their weight loss goals with Wegovy or have hit a plateau.
Enhanced blood sugar control with Mounjaro
Mounjaro has shown significant benefits for blood sugar management in people with type 2 diabetes. Clinical trials have demonstrated that tirzepatide, the active ingredient in Mounjaro, can help lower blood sugar levels more effectively than other diabetes medications, including semaglutide.
In one study, participants using Mounjaro experienced a greater reduction in HbA1c levels (a marker of long-term blood sugar control) compared to those using other treatments. This makes Mounjaro a promising option for individuals with type 2 diabetes who require better blood sugar management.
Side effects tolerance issues with Wegovy
Both medications share similar side effects, like nausea, stomach pain, diarrhea, and constipation. However, some people may tolerate Mounjaro better, as the side effect profile can vary from person to person.
It’s important to monitor how your body responds to the medication and report any concerns or unusual symptoms to your doctor. Your healthcare provider can help adjust the treatment plan to ensure the best possible outcome while minimizing discomfort.
Insurance and cost considerations
The cost of Wegovy and Mounjaro can vary depending on your insurance coverage and where you live. Many insurance plans may not cover weight-loss medications like Wegovy but coverage can differ by plan. Mounjaro may be more likely to be covered if prescribed for Type 2 diabetes, as it’s FDA-approved for that use.
The manufacturers of Wegovy and Mounjaro offer savings cards that can help reduce out-of-pocket costs for eligible patients.
Wegovy savings card
The Wegovy Savings Card is offered by the manufacturer, Novo Nordisk, to help people save money with or without insurance. It helps those with commercial insurance to reduce their out-of-pocket costs of Wegovy to as low as $0/month by providing financial assistance to cover part of the cost, making the medication more affordable for qualifying individuals. Individuals without insurance coverage can pay $650 per month with the card.
The program is typically available to those with commercial insurance, or without any insurance coverage, and excludes those with government-sponsored insurance such as Medicare and Medicaid.
Mounjaro savings card
The Mounjaro Savings card is a savings program offered by Eli Lilly that helps reduce the cost of medication for people with commercial or private insurance. If you qualify, you can use the card to get Mounjaro for as little as $25/month. Those with government-sponsored insurance are not eligible.
Many insurance plans including Medicare and Medicaid will cover Mounjaro if used for type 2 diabetes. However, your copay will vary by plan and your out-of-pocket costs will be higher until you meet your deductible. Medicare Part D plans cover many diabetes medications, including Mounjaro.
Who should not switch to Mounjaro?
The criteria for using Wegovy and Mounjaro are similar. People with certain health conditions or medical histories cannot take these medications. It’s important to talk to your healthcare provider before starting Mounjaro so they can help you decide if it’s right for you based on your health history.
You should not take Mounjaro if you have any of these conditions:
- Type 1 diabetes: Mounjaro is not approved for Type 1 diabetes. Talk to your doctor about other treatments.
- Thyroid cancer: Mounjaro may increase the risk of thyroid cancer, especially if you’ve had it before or have a family history. Avoid Mounjaro if you have a history of thyroid cancer.
- Pancreatitis: If you’ve had pancreatitis, talk to your doctor to see if Mounjaro is right for you.
- Allergies: If you’re allergic to Mounjaro, avoid using it to prevent serious allergic reactions.
Wegovy vs. Mounjaro: Key differences
The main differences between Wegovy and Mounjaro are their mechanism of action, active ingredients, and effectiveness. Wegovy has the active ingredient semaglutide and Mounjaro has tirzepatide.
Mechanism of action
Both semaglutide and tirzepatide are GLP-1 (glucagon-like peptide 1) agonists. They work by mimicking natural hormones, incretins, released by the gut after eating, which help control insulin, slow down how fast your stomach empties, and reduce extra sugar produced by the liver. This leads to effects like decreased hunger and feeling full longer.
Semaglutide is a GLP-1 only, while tirzepatide is a dual agonist with another natural hormone called GIP. GIP provides extra benefits, like reducing fat buildup, improving bone health, and lowering stomach acid.
Mounjaro works by activating both GLP-1 and GIP receptors, increasing insulin secretion, decreasing glucose production by the liver, reducing hunger and cravings, and promoting satiety leading to less food intake and weight loss.
FDA-approvals
Wegovy is FDA-approved for long-term weight management in people with obesity or overweight with weight-related health issues. It can also lower the risk of heart attacks and strokes in people with heart disease and is FDA-approved for the risk of cardiovascular events in adults with obesity or overweight and cardiovascular disease.
Wegovy contains semaglutide, which helps control appetite by mimicking a natural hormone called GLP-1. Semaglutide is also found in Ozempic and Rybelsus, which are used to treat Type 2 diabetes.
Mounjaro is FDA-approved for managing Type 2 diabetes. It contains tirzepatide, which combines a GLP-1 receptor agonist with another type of glucose-dependent insulinotropic polypeptide (GIP). While it’s mainly used for diabetes, doctors may also prescribe it off-label to help with weight loss, especially for people with both diabetes and obesity.
Dosage and administration
Mounjaro and Ozempic come as pre-filled subcutaneous weekly injections taken on the same day of the week and can be taken with or without food.
Ozempic and Mounjaro are weekly injections administered under the skin (subcutaneously) of your stomach, upper arm, or thigh.
Mounjaro comes in a pre-filled pen for subcutaneous injection. It is available in six strengths: 2.5 mg (starting dose), 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg (maximum dose). The dosage is typically adjusted based on individual needs and treatment goals.
Wegovy comes in a pre-filled pen for subcutaneous injection. It is available in five strengths: 0.25 mg (starting dose), 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg (maximum dose).
Effectiveness with weight loss and blood sugar control
Novo Nordisk’s 68-week study showed an average weight loss of 15% with once-weekly semaglutide. In comparison, Eli Lilly’s 72-week study showed an average weight loss of 21% with once-weekly tirzepatide.
A study that directly compares tirzepatide and semaglutide in people with type 2 diabetes. It shows that tirzepatide leads to slightly more weight loss than semaglutide. However, this study involved people with type 2 diabetes, not those being treated for obesity.
A head-to-head trial comparing semaglutide and tirzepatide shows that tirzepatide promotes significantly more weight loss than semaglutide. People taking tirzepatide showed an average weight loss of 20.2% vs. 13.7% with semaglutide.
Side effects
Switching from Wegovy to Mounjaro can cause potential side effects. Your body might react differently when you change medications. Since both drugs work in similar ways, you may have side effects like stomach issues and changes in blood sugar levels.
Common side effects of Mounjaro include:
- Nausea
- Vomiting
- Diarrhea
- Decreased appetite
- Constipation
- Indigestion
- Stomach pain
Common side effects of Wegovy include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
- Some people may also experience headaches or fatigue.
Serious side effects of Wegovy and Mounjaro can include inflammation of the pancreas (pancreatitis), low blood sugar, severe allergic reactions, gallbladder problems, kidney issues, and vision changes.
Cost and insurance coverage
You might want to switch from Wegovy to Mounjaro due to cost. Both medications require a prescription and insurance coverage can vary. Many insurance plans don’t cover weight-loss drugs, but they may cover Mounjaro if it’s prescribed for Type 2 diabetes.
Check with your insurance to see what’s covered. Depending on your plan, Mounjaro might be more affordable.
Wegovy, from Novo Nordisk, and Mounjaro from Eli Lilly, are both known to be safe and effective medications. However, they should not be used together with other GLP-1 or GIP receptor agonists.
Wegovy vs. Mounjaro: Key differences
| Wegovy | Mounjaro | |
|---|---|---|
| Manufacturer | Novo Nordisk | Eli Lilly |
| Active ingredients | Semaglutide | Tirzepatide |
| Mechanism of action | GLP-1 receptor agonist | GLP-1 and GIP receptor agonist |
| Administration | Once a week subcutaneously (under the skin) | Once a week subcutaneously (under the skin) |
| Efficacy | Helps in weight loss and lower the risk of serious heart problems like heart attacks and stroke in obese or overweight adults with heart disease. | Greater reduction in HbA1c levels and more weight loss. |
| Dosage forms | Injectable (pre-filled pen) | Injectable (pre-filled pen) |
| Available strengths | 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Dose | Starting dose: 0.25 mg Maintenance dose: 1.7 mg or 2.4 mg Maximum dose: 2.4 mg | Starting dose: 2.5 mg Maintenance dose: 5 mg, 10 mg, and 15 mg Maximum dose: 15 mg |
| Blood sugar reduction | Reduction in HbA1c by about 1%-1.5% | Significant reduction in HbA1c up to 2.30% |
| Body weight reduction | Up to 15% of an individual’s total body weight over 68 weeks. | Up to 20% of an individual’s total body weight over 72 weeks. |
| Side effects frequency | Nausea: 16% Vomiting: 9.2% Diarrhea: 9% Stomach pain: 7% Constipation: 5% | Nausea: 12% Diarrhea: 12% Vomiting: 9% Stomach pain: 6% Constipation: 6% |
| Covered by insurance? | Not always | Yes, when prescribed for Type 2 diabetes |
Wegovy to Mounjaro dosage conversion chart
Wegovy and Mounjaro are administered subcutaneously (under the skin) of the stomach, thigh or upper arm.
The doses of Wegovy and Mounjaro are different, but both medications are started at a low dose and gradually increased until a maintenance dose is reached. Mounjaro has a wider range of doses than Wegovy.
- Wegovy doses: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg once weekly
- Mounjaro doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg once weekly
Because these medications have different mechanisms of action in the body, there are no dose equivalents or direct ways to convert doses. The appropriate dosage for Mounjaro after stopping Wegovy will depend on factors like individual health conditions, and response to treatment. You will need to work closely with your healthcare provider who will closely monitor your progress and side effects.
Correct dosing is essential when switching from Wegovy to Mounjaro to avoid side effects and ensure the medication works effectively. Incorrect dosing can lead to either intensified side effects or reduced efficacy, preventing the medication from reaching its full potential.
When switching from Wegovy to Mounjaro, your doctor will determine the appropriate starting dose and titration schedule based on factors like:
- Your previous Wegovy dosage
- Weight loss progress on Wegovy
- Tolerance of side effects
- Overall health status
- Treatment goals
Here’s some general guidance for starting doses when switching from Wegovy to Mounjaro based on your previous Wegovy dose:
- Wegovy 0.25 mg to 0.5 mg: Consider starting Mounjaro at 2.5 mg once weekly.
- Wegovy 1 mg to 1.7 mg: Consider starting Mounjaro at 5 mg once weekly.
- Wegovy 2 mg to 2.4 mg: Consider starting Mounjaro at 7.5 mg or 10 mg once weekly.
Starting dose
Healthcare providers typically start new patients on Wegovy at 0.25mg weekly and Mounjaro at 2.5 mg once weekly for the first 4 weeks.
Titration schedule
If tolerated, the dose is escalated every 4 weeks until a maintenance dose is reached.
Wegovy dose is typically increased to 1 mg once weekly for 4 weeks, and if tolerated, increased to 1.7 mg once weekly for the next 4 weeks or ongoing.
Mounjaro dose is typically increased to 5 mg once weekly for 4 weeks, and if tolerated, increased to 7.5 mg once weekly for the next 4 weeks or ongoing.
Maintenance dose
The standard maintenance doses for Wegovy are either 1.7 mg once weekly or 2.4 mg once weekly.
The standard maintenance doses for Mounjaro are 5 mg once weekly, 10 mg once weekly, or 15 mg once weekly.
Maximum dose
The maximum dose of Wegovy is 2.4 mg once weekly, and the maximum dose for Mounjaro is 15 mg once weekly. You should never exceed this dose.
Wegovy to Mounjaro conversion chart
| Wegovy | Mounjaro | |
|---|---|---|
| Starting dose: | 0.25 mg once weekly for 4 weeks | 2.5 mg once weekly for 4 weeks |
| Maintenance dose: | 0.5 mg to 1.7 mg once weekly | 5 mg to 15 mg once weekly |
| Maximum dose: | 2.4 mg once weekly | 15 mg once weekly |
Mounjaro to Wegovy conversion chart
| Mounjaro | Wegovy | |
|---|---|---|
| Starting dose: | 2.5 mg once weekly for 4 weeks | 0.25 mg once weekly for 4 weeks |
| Maintenance dose: | 5 mg to 15 mg once weekly | 0.5 mg to 1.7 mg once weekly |
| Maximum dose: | 15 mg once weekly | 2.4 mg once weekly |
Wegovy and Mounjaro equivalent doses
| Wegovy dose | Equivalent Mounjaro dose | Notes |
|---|---|---|
| 0.5 mg | 2.5 mg | Starting dose for both medications is gradually increased. |
| 1 mg | 5 mg | Typical maintenance dose for both medications to keep blood sugar levels stable. |
| 1.7 mg | 7.5 mg | Higher doses for improved HbA1c reduction and increased weight loss. |
| 2.4 mg | 10 mg, 12.5 mg, 15 mg | Mounjaro provides higher doses for a more intense treatment, which are not available in Ozempic. |
How to safely switch from Wegovy to Mounjaro
If switching from Wegovy to Mounjaro, follow these steps to ensure a safe conversion process. Here’s an example of how the process might go:
- Consult with your healthcare provider: Always talk to your doctor before changing your medication or dosage. They will guide you on how to start Mounjaro safely and may suggest a gradual dose adjustment.
- Share your medical history: Tell your doctor about any medications you’re taking so they can check if Mounjaro is a good option for you.
- Find the right dose: Work with your doctor to identify the right dose of Mounjaro based on how your body responds and any side effects you have.
- Create a plan: Work with your doctor to make a plan for stopping Wegovy and starting Mounjaro. A clear timeline will help manage the switch.
- Taper off Wegovy: If your doctor recommends it, follow their instructions to gradually reduce your Wegovy dose before completely stopping to take the medication.
- Start Mounjaro: Start using Mounjaro as your doctor prescribed and pay attention to how your body reacts.
- Dosage adjustments: When switching from Wegovy to Mounjaro, your doctor will likely adjust the dosage of Mounjaro based on several factors. These include your previous Wegovy dose, how well you respond to the medication, tolerance of any side effects, and your overall health status.
- Monitor for side effects: Both medications have similar side effects, but Mounjaro may cause stronger side effects due to dual-action formulation. You might experience stomach issues or low blood sugar symptoms like dizziness, shaking, or confusion. Contact your doctor if symptoms worsen.
- Monitor blood sugar and weight: Keep track of your blood sugar levels and weight during the switch to monitor the medication’s effectiveness. Report any significant changes to your doctor.
- Follow-up visits: Schedule a follow-up visit with your provider to check how you’re doing on Mounjaro. Your doctor may adjust your treatment based on your response to the medication.
How to switch from Wegovy to Mounjaro
| Time passed since the last dose of Wegovy | When to take the first dose of Mounjaro |
|---|---|
| 6 days | In 1 day |
| 5 days | In 2 days |
| 4 days | In 3 days |
| 3 days | In 4 days |
| 2 days | In 5 days |
| 1 day | In 6 days |
| 7 or more days | Today |
Key considerations when switching medications
When switching from Wegovy to Mounjaro, keep these key considerations in mind:
- Understand dosage equivalents: There is no direct conversion chart for switching from Wegovy to Mounjaro because they work differently in the body. When transitioning, your doctor will adjust your Mounjaro dosage based on factors like your previous Wegovy dose, how well you responded to it, and your treatment goals.
- Timing the transition: When switching from Wegovy to Mounjaro, your doctor will guide the timing based on your needs. You may either stop Wegovy and start Mounjaro immediately or gradually taper off Wegovy while starting Mounjaro at a lower dose.
- Potential side effects: While both medications are generally well-tolerated, it’s important to monitor for any side effects, particularly if they become severe or persistent. Common side effects include stomach upset, decreased appetite, and potential low blood sugar (for those with diabetes). If you experience any severe reactions, such as difficulty breathing, severe nausea, or signs of an allergic reaction (rash, swelling), it is important to contact your healthcare provider immediately.
- Cost and insurance coverage: The cost of Wegovy and Mounjaro can vary significantly, and insurance coverage for both medications may differ based on your insurance plan. Generally, Wegovy and Mounjaro are expensive medications, and many insurance plans do not cover weight-loss treatments. However, Mounjaro may be more likely to be covered if prescribed for Type 2 diabetes, as it is FDA-approved for this condition. Contact your insurance provider to verify coverage details.
- Medical history: Before switching from Wegovy to Mounjaro, it’s important to discuss your medical history and any current medications with your doctor. Certain medical conditions or other medications you’re taking may affect how well Mounjaro works for you or increase the risk of side effects.
- Individualized treatment Goals: Your doctor may need to adjust the dosage based on factors like your health, weight, and how your body responds to the medication.
Potential risks and considerations
Switching from Wegovy to Mounjaro may offer benefits, but there are potential risks and considerations to keep in mind:
- Side effects: Both medications have similar side effects, such as nausea, vomiting, and gastrointestinal issues, but how you respond to each drug may differ. Switching may result in different or more severe side effects.
- Dosage adjustments: Since Mounjaro works differently and has a different dosing schedule, it’s essential to follow your healthcare provider’s guidance carefully. Starting at the wrong dose or increasing the dose too quickly may lead to discomfort or reduced effectiveness.
- Medical history considerations: If you have a history of thyroid issues, pancreatitis, or other conditions, Mounjaro may not be appropriate. Discuss your medical history with your doctor before making the switch.
- Treatment goals: Mounjaro may offer more significant weight loss for some people, but it might not be right for everyone. Switching medications should align with your weight loss and health goals.
- Weight regain: It can occur temporarily during the transition from Wegovy to Mounjaro as your body adjusts to the new medication. This fluctuation is normal and may happen in the early stages, especially if you’re still in the process of gradually increasing your dosage.
- Insurance hurdles: Insurance coverage can be a challenge when switching from Wegovy to Mounjaro, as it may require another prior authorization, especially if there are changes in the dosage or treatment plan. Insurance companies might not automatically cover new medications or dosage adjustments, so it’s important to check with your insurance provider to understand what is covered.
Tips for a safe and smooth transition
Here are some tips to make the transition from Wegovy to Mounjaro smoother:
- Keep a medication log: It’s a good idea to track your medication dosages and any side effects you may experience when switching from Wegovy to Mounjaro. This helps you notice patterns, and your healthcare provider can use this information to adjust your treatment plan if needed.
- Communication with doctor: Open communication with your healthcare provider is key during the transition. Let them know how you’re feeling, whether you’re experiencing side effects, or if you have any concerns.
- Follow-up doctor appointments: Attending follow-up appointments with your doctor is crucial to monitor your progress after switching medications. Your doctor will assess how Mounjaro is working for you, check for any potential side effects, and adjust your dose if needed.
Frequently asked questions
Is Mounjaro more effective than Wegovy for weight loss?
Mounjaro and Wegovy are both effective for weight loss, but studies show that Mounjaro may help people lose more weight than Wegovy.
What are the most common side effects of Mounjaro?
The most common side effects of Mounjaro include nausea, vomiting, diarrhea, and stomach pain. Some people may also experience loss of appetite or constipation.
Will my insurance cover Mounjaro?
Whether your insurance covers Mounjaro depends on your specific plan and its formulary. It’s best to contact your insurance company directly to find out if it’s covered and what your out-of-pocket costs might be.
What if I experience side effects after switching?
If you experience side effects after switching to Mounjaro, you should contact your healthcare provider for advice. They may adjust your dosage or suggest ways to manage the symptoms.
Can I take both medications together?
It’s not recommended to take Wegovy and Mounjaro together. Both medications work in similar ways and can cause overlapping side effects.
Will I regain weight during the transition?
You might experience some weight regain during the transition between medications. This varies from person to person. Following your doctor’s advice on diet and exercise can help reduce the chances of regaining weight.
Is Mounjaro stronger than Wegovy?
Mounjaro is considered stronger than Wegovy for weight loss in some studies, as it may lead to more weight loss.
Does insurance cover switching?
Insurance coverage for switching medications depends on your plan and its specific policies. You should check with your insurance company to see if switching from one medication to another is covered and if there are any additional requirements.
How long until I see results with Mounjaro?
You may start seeing results with Mounjaro within a few weeks, but it can take 3 to 6 months to notice significant weight loss.
Can I overlap Wegovy and Mounjaro doses?
It’s not recommended to overlap Wegovy and Mounjaro doses without your doctor’s approval.
What if I was on Wegovy’s highest dose (2.4 mg)? Do I still start Mounjaro at 2.5 mg?
If you were on Wegovy’s highest dose, your doctor might recommend starting Mounjaro at a lower dose (typically 2.5 mg) for four weeks and then gradually increasing it every four weeks until you reach a maintenance dose.
What if I experience severe side effects during the transition?
If you experience severe side effects during the transition, you should contact your doctor immediately. They may adjust your medication or help you manage the symptoms.
Can I go back to Wegovy if Mounjaro’s dosage doesn’t work?
Yes, you can go back to Wegovy if Mounjaro’s dosage doesn’t work for you, but you should do so under your doctor’s guidance.
Bottom line
There is no direct conversion chart between the two, so your healthcare provider will personalize the Mounjaro dose schedule based on your individual needs and treatment goals.
Switching from Wegovy to Mounjaro involves several important considerations, including the dosage adjustment based on your previous Wegovy treatment, how you respond to the new medication, and any side effects you may experience.
Make healthy lifestyle changes like eating well and increasing physical activity to make your treatment more effective.
Discussing your weight loss journey and treatment options with your doctor will help you make an informed decision and ensure a safe and effective transition.
